Markus Warmuth, President & CEO at Monte Rosa Therapeutics, Inc. (GLUE), sold 9,500 shares at $23.18 ($220K) on 2026-07-16, disclosed to the SEC on 2026-07-17.
Open-market sale of $220k GLUE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-04-15 | $141K | — | Filing → |
| GLUE | SELL | 2026-03-04 | $98K | — | Filing → |
| GLUE | SELL | 2026-01-09 | $257K | — | Filing → |